LEUKAEMIA DRUG

Early day motion 1483, tabled 26 June 2003 by Ian Gibson (Labour). Signed by 47 members.

That this House welcomes the National Institute for Clinical Excellence's provisional recommendation that Glivec should be available on the NHS as a first-line treatment of people with chronic myeloid leukaemia in the chronic phase; and calls on NICE to issue final guidance as soon as possible.

Signatures by party: Labour 30, Liberal Democrat 10, DUP 2, Plaid Cymru 2, UUP 2, Independent Ulster Unionist 1.